Comparing Arthroscopic Tennis Elbow Release With Arthroscopic Debridement
Launched by OTTAWA HOSPITAL RESEARCH INSTITUTE · Sep 8, 2014
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying two different surgical options for treating chronic tennis elbow, a condition that causes pain on the outer part of the elbow. The trial will compare a procedure called arthroscopic release, which aims to relieve pressure and improve movement, with arthroscopic debridement, which involves cleaning out damaged tissue. The goal is to find out which method works better and to help doctors make informed recommendations for treating this condition.
To participate in the trial, you need to be an adult (at least 18 years old) who has been experiencing tennis elbow symptoms for more than six months and has not found relief from other treatments. If you are interested, you will undergo a thorough evaluation to ensure you're a good fit for the study. Participants will be randomly assigned to receive one of the two procedures, and everyone will be closely monitored throughout the study to track their progress and recovery. It's important to note that some individuals may not be eligible if they have other medical issues that explain their symptoms or if they have had previous surgeries on the elbow. This trial is currently recruiting, and all genders are welcome to participate.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Symptoms consistent with lateral epicondylitis persisting for \>6 months, and have failed conservative management
- • Adult, skeletally mature (\>18yrs)
- • Provision of informed consent
- Exclusion Criteria:
- • Alternative diagnosis that better explain their symptoms
- • Previous elbow trauma or surgery
- • Case involving workplace insurance claims (e.g. WSIB)
- • Unwilling, or unlikely in the opinion of the investigator to be followed for the duration of the study (e.g., patient refusal, unfixed address, plans to move...etc.)
- • Cognitive difficulties that prevent ability to provide informed consent and reliable completion of questionnaires
- • Bilateral lateral epicondylitis
About Ottawa Hospital Research Institute
The Ottawa Hospital Research Institute (OHRI) is a leading academic research institute dedicated to advancing health and healthcare through innovative research and evidence-based practices. Affiliated with The Ottawa Hospital and the University of Ottawa, OHRI fosters a collaborative environment that brings together clinicians, scientists, and trainees to conduct groundbreaking clinical trials and translational research. With a focus on improving patient outcomes, OHRI specializes in a wide range of fields, including cancer, cardiovascular health, and regenerative medicine. The institute is committed to ethical research practices and the dissemination of knowledge to enhance public health and inform healthcare policy.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ottawa, Ontario, Canada
Patients applied
Trial Officials
J W Pollock, MD
Principal Investigator
The Ottawa Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials